ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1863

Non-Invasive Investigation of Perfusion, Microvascular Structure, Erythema, Oxidative Stress and Oxygenation in Healthy Controls and in Patients with Primary and Secondary Raynaud’s Phenomenon

Andrea Murray1,2, Tonia Moore3, Joanne Manning4, Ian Poxon2, Graham Dinsdale1, Michael Berks5, Sarah Leggett6, Mark Dickinson2 and Ariane L. Herrick1, 1Centre for Musculoskeletal Research, University of Manchester, MAHSC, Salford Royal Hospital, Manchester, United Kingdom, 2Photon Science institute, University of Manchester, Manchester, United Kingdom, 3Centre for Musculoskeletal Research, University of Manchester, MAHSC, Salford Royal Hospital, Salford, United Kingdom, 4Rheumatology Department, Salford Royal NHS Foundation Trust, Salford, United Kingdom, 5Centre for Imaging Sciences, University of Manchester, Institute of Population Health, Manchester, United Kingdom, 6Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Connective tissue diseases, Imaging techniques and systemic sclerosis, Raynaud's phenomenon

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: It is well established that measurements of cutaneous microvascular dysfunction (measured with laser Doppler imaging [LDI]) and structural abnormality (measured with nailfold capillaroscopy [NC]) differentiate between primary Raynaud’s phenomenon (PRP) and systemic sclerosis (SSc).  Spectroscopy to measure free radical induced oxidative stress (OS) and oxygenation (OX) has been less well studied despite both being implicated in SSc pathogenesis. The aim of this study was to evaluate all of these parameters and to determine how the additional information provided by spectroscopy compares to established techniques in a population of patients with SSc (subtyped as limited or diffuse cutaneous (lcSSc, dcSSc) depending upon skin involvement), PRP and undifferentiated connective tissue disease (UCTD) and in healthy controls (HC).

Methods: Perfusion images (dual wavelength [superficial capillary and deeper thermoregulatory microcirculation layers, LDI]) were taken of the hand pre and post local heating. Distal dorsal difference (DDD, digit-dorsum) was calculated at baseline and perfusion increase (POST/PRE) calculated at the digit and dorsum. Nailfold capillaroscopy (NC) was carried out at 200x magnification over the whole nailbed on the non-dominant ring finger. Capillary density and width were calculated from images using automated software.  Spectroscopy (light shone onto the skin with a fibre and collected by spectrometer) was carried out at 9 sites of the body. Oxidative stress (OS) measurements were taken with UV light and erythema (E, pseudo-measure of blood flow) and oxygenation (OX) with white light. Comparisons were made between groups with an ANOVA (STATA).

Results: 92 patients with lcSSc, 47 with dcSSc, 31 with PRP, 35 with UCTD, 61 HC were assessed. Data is presented in table 1. LDI showed smaller values for DDD (thermoregulatory layer) and POST/PRE digit and dorsum (thermoregulatory and capillary layers) for SSc vs HC. NC density was significantly lower and width significantly higher in the SSc vs HC group. OS was significantly increased in 7/9 sites in SSc vs HC groups. E was significantly lower at 8/9 sites for the SSc vs HC group. OX was lower at the digit in SSc vs HC group but overall showed no trend for increase or decrease.

Conclusion: The data confirms microvascular dysfunction and structural changes in SSc in a large data set. In addition these changes are matched by increased free radical stress (OS). These changes now need to be measured prospectively and these studies are underway.

Table 1. LDI, spectroscopy (E, OX, OS) and NC data [Median (IQR)] at the digit and dorsum.

Technique

Parameter

HC

n=61

PRP

n=31

UCTD

n=35

LcSSc

n=92

DcSSc

n=47

P value (one-way ANOVA)

LDI Red DDD (Arb PU)

197 (89 to 261)

118 (36 to 255)

175 (61 to 285)

162  (39 to 258)

42 (-9 to 159)

0.0019**

Red POST/PRE digit

2.23  (1.68 to 2.98)

2.16 (1.12 to 2.71)

2.74 (2.00 to 3.57)

2.00  (1.41 to 2.53)

1.54 (1.28 to 2.46)

0.0093**

Red POST/PRE dorsum

1.99 (1.59 to 2.88)

2.72 (2.12 to 3.30)

2.51 (1.81 to 4.13)

1.98 (1.47 to 2.95)

1.87 (1.26 to 3.00)

0.0064**

Green DDD (Arb PU)

5.5 (-7 to 25.5)

1.0 (-9.2 to  23.3)

0.0 (-7.5  to 16)

0.0 (-9 to 23)

1.1 (-16 to 14.5)

0.4302

Green POST/PRE heating finger

1.3 (1.2  to  1.7)

1.3 (1.0  to  1.8)

1.4 (1.2  to 2.4)

1.3 (1.2  to  1.8)

1.2 (1.0  to  1.5)

0.0330*

Green POST/PRE dorsum

1.4 (1.2  to  1.5)

1.5 (1.3  to  1.9)

1.6 (1.3  to  2.3)

1.4 (1.2  to  1.8)

1.4 (1.2  to 1.6)

0.0136**

NC Vessel density

13.21 (10.99  to 15.79)

13.50 (10.05 to 14.60)

11.45 (8.81  to 14.10)

9.07 (6.84  to 11.49)

8.98 (6.73  to 11.19)

<0.0001***

Mean width (mm)

13.37 (12.25  to 15.54)

14.03 (12.91  to 15.59)

14.78 (12.76  to  16.64)

16.60 (14.14  to 21.27)

17.38 (13.85  to 20.95)

<0.0001***

Spectroscopy (Arbitrary units) OS digit

3.86 (3.27 to 4.64)

3.51 (2.80 to 3.95)

3.61 (3.21 to 4.72)

4.67 (3.7 to 5.40)

4.32 (3.78 to 5.06)

0.1706

OS dorsum

3.56 (3.17 to 4.27)

3.62 (2.60 to 4.21)

3.61 (3.00 to 4.01)

4.32 (3.84 to 5.25)

4.20 (3.34 to 4.78)

<0.0001***

E digit

222.9 (218.6 to 224.9)

218.1 (213.0 to 223.5)

218.6 (208.8 to 222.4)

220.4 (214.0 to 225.7)

220.5 (207.9 to 225.3)

0.0229*

E dorsum

213.8 (208.3 to 219.0)

206.4 (197.4 to 216.0)

210.2 (200.1 to 218.9)

207.0 (198.9 to 214.3)

203.4 (192.8 to 209.7)

0.0003**

OX digit

0.15 (0.08  to 0.21)

0.17 (0.12  to 0.23)

0.22 (0.13  to 0.30)

0.10 (0.02  to 0.23)

0.13 (0.35  to 0.18)

0.0021**

OX dorsum

0.09 (0.01  to 0.14)

0.12 (-0.00  to 0.21)

0.07 (0.03  to 0.18)

0.11 (0.05  to 0.16)

0.12 (0.06  to 0.18)

0.7213

* Significant at the p<0.05 level, ** Significant at the p<0.01 level, *** Significant at the p<0.0001 level


Disclosure: A. Murray, None; T. Moore, None; J. Manning, None; I. Poxon, None; G. Dinsdale, None; M. Berks, None; S. Leggett, None; M. Dickinson, None; A. L. Herrick, None.

To cite this abstract in AMA style:

Murray A, Moore T, Manning J, Poxon I, Dinsdale G, Berks M, Leggett S, Dickinson M, Herrick AL. Non-Invasive Investigation of Perfusion, Microvascular Structure, Erythema, Oxidative Stress and Oxygenation in Healthy Controls and in Patients with Primary and Secondary Raynaud’s Phenomenon [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/non-invasive-investigation-of-perfusion-microvascular-structure-erythema-oxidative-stress-and-oxygenation-in-healthy-controls-and-in-patients-with-primary-and-secondary-raynauds-phenomenon/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-invasive-investigation-of-perfusion-microvascular-structure-erythema-oxidative-stress-and-oxygenation-in-healthy-controls-and-in-patients-with-primary-and-secondary-raynauds-phenomenon/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology